Tuesday, April 16, 2013

Oncology Management Industry Outlook

IIR’s collaborative Summit for Oncology Management will deliver dedicated sessions on the outlook of oncology management to prepare you for the evolving reimbursement landscape and the effect on you and your business, including:

Industry Trends: What’s Happening in Healthcare? Jayson Slotnik, Partner, Health Policy Strategies, LLC

What’s the Impact of Healthcare Reform on Cancer Care?

Elan Rubinstein, PharmD, MPH, EB Rubinstein Associates

• Michael Kolodziej, MD, FACP, Medical Director, Oncology Strategy,Office of the Chief Medical Officer, Aetna
• William T. McGivney, PhD, Former NCCN CEO, McGivney Global Advisors
• Jack Whelan, Patient Advocate & Member, Personalized Medicine Coalition
The Use of Screenings, Biomarkers & Diagnostic Testing to Increase Positive Outcomes and Manage Cost of Oncology

Paul Howard, Director and Senior Fellow Center for Medical Progress, Manhattan Institute for Policy Research

• William T. McGivney, PhD, Former NCCN CEO, McGivney Global Advisors
• Oscar Puig, Biomarker Lead in Oncology, Translational Clinical Research Center, Roche
• Maurie Markman, MD, Senior Vice President, Clinical Affairs, Cancer Treatment Centers of America

To learn more, download our brochure.

As a readerr of the healthcare insights blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter

No comments: